EU External Trade - Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, Other

The main extra-EU suppliers of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, Other are 🇺🇸 United States, 🇮🇸 Iceland, 🇨🇳 China. 🇺🇸 United States leads with 38.4% of total imports (€43.2M). The HHI concentration index stands at 2085, indicating a Moderate market.

The main extra-EU export markets for Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, Other are 🇨🇳 China, 🇺🇸 United States, 🇨🇭 Switzerland. 🇨🇳 China absorbs 29.3% of European exports (€93.0M).

Within the EU, the leading importers of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, Other are 🇮🇪 Ireland, 🇩🇪 Germany, 🇧🇪 Belgium. 🇮🇪 Ireland accounts for 31.6% of EU imports.

The year 2025 marked a turning point: both imports and exports were surging, shifting by 38.4% and 61.3% respectively.